Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice.

Por Webster, L. K., Cosson, E. J., Stokes, K. H., Millward, M. J.
Publicado em 1996

Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.

Por Millward, M. J., Cantwell, B. M., Dowsett, M., Carmichael, J., Harris, A. L.
Publicado em 1991

Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.

Por Millward, M. J., Cantwell, B. M., Munro, N. C., Robinson, A., Corris, P. A., Harris, A. L.
Publicado em 1993

A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.

Por Lind, M. J., Cantwell, B. M., Millward, M. J., Robinson, A., Proctor, M., Simmons, D., Carmichael, J., Harris, A. L.
Publicado em 1992

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma

Por Creaney, J, Segal, A, Sterrett, G, Platten, M A, Baker, E, Murch, A R, Nowak, A K, Robinson, B W S, Millward, M J
Publicado em 2008

The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer.

Por Lind, M. J., Gumbrell, L., Cantwell, B. M., Millward, M. J., Simmonds, D., Proctor, M., Chapman, F., McCann, E., Middleton, I., Calvert, A. H.
Publicado em 1995

The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study

Por Millward, M J, House, C, Bowtell, D, Webster, L, Olver, I N, Gore, M, Copeman, M, Lynch, K, Yap, A, Wang, Y, Cohen, P S, Zalcberg, J
Publicado em 2006